Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) went down 2.19% to $1.79 on about 5.99 million shares. Last month, WBB Securities and CRT Capital downgraded the stock a Hold, down from Strong Buy while CRT now rates the stock a Fair Value, down from Buy previously. WBB lowered its price target on ARNA shares from $7 to $2.
Over the past 52-week, the stock had traded within the range of $1.51-$8.
Alexza Pharmaceuticals, Inc. (NASDAQ:ALXA) jumped 0.67% to $1.35 on over 1.93 million shares. This week, the company announced that it has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA or Agency) regarding its New Drug Application (NDA) for AZ-004 (Staccato loxapine), submitted as Adusuve Staccato (loxapine) inhalation aerosol, 5 mg and 10 mg.
The stock opened at $1.35 and is trading within the range of $1.33-$1.39. At current market price, the market capitalization of the company stands at $71.40 million.
StemCells, Inc. (NASDAQ:STEM) dropped 3.26% to $0.917 on about 1.77 million shares. StemCells, Inc. is engaged in the research, development, and commercialization of stem cell therapeutics and related enabling technologies for academia and industry.
The 52-week range of the stock is $0.75-$1.72. At current market price, the market capitalization of the company stands at $116.66 million.
Labopharm Inc. (NASDAQ:DDSS) soared 11.46% to $1.07 on over 1.53 million shares. Labopharm Inc. is an international, specialty pharmaceutical company focused on optimizing the performance of existing drugs by incorporating its advanced controlled-release technologies.
To get up to date market moving news please visit the Wall Street Grand blog at www.wallstreetgrand.com. Wall Street Grand is a leading online Financial Newsletter who specializes in finding undervalued and undiscovered stocks. Visit the Wall Street Grand Club today and Join Free by clicking the SAFE LINK.
Disclaimer:
Wall Street Grand's stock profiles are intended to be stock ideas, NOT recommendations. Please do your own research before investing. It is crucial that you at least look at current SEC filings and read the latest press releases. Information contained in this profile was extracted from current documents filed with the SEC, the company web site and other publicly available sources deemed reliable. The purpose of this advertisement, like any advertising, is to provide coverage and awareness for the company. Never invest into a stock we discuss unless you are prepared to lose your entire investment. WSG has not been compensated for this press release and does not own any of the stocks mentioned in this release. To read our full detailed disclaimer on each stock please visit our profiles page at wall street grand and scroll to the bottom of each profile. WSG may or may not trade the stocks mentioned in this alert which can affect the price of the stock The information provided in this advertisement is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject us to any registration requirement within such jurisdiction or country. For our full disclosure please visit - http://www.wallstreetgrand.com/disclosure.html
